Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis.

All site content, except where otherwise noted, is licensed under a Creative Commons BY license. Please let us know where and how you use MSDF material.

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu

Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis.

MSDF Footer

Search form

Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis.